www.fdanews.com/articles/138470-nsvascular-signs-exclusive-license-with-ucla-for-thin-film-nitinol-technology
NSVascular Signs Exclusive License With UCLA for Thin-Film Nitinol Technology
July 18, 2011
NeuroSigma announced the formation of a majority owned subsidiary, NSVascular, and the signing of an exclusive license with the University of California, Los Angeles covering its medical applications of Thin-Film Nitinol (TFN) technology.
NewsMedical
NewsMedical